Immuno Oncology Assays Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Immuno Oncology Assays Market to value over US $ 6 Billion and register a CAGR of over 12% during the forecast period from 2019 to 2026.
Rising
exposure to carcinogenic agents and a subsequent rise in the number of cancer
cases and casualties is surging the demand for effective treatment will further
boost industry growth during the forecast timeline. Continuous research for
novel cancer treatment is projected to foster immuno oncology assays market
growth. The significant factors contributing to the growth of the global immuno
oncology assays market are increasing incidences of cancer and rising adoption
of targeted therapy over traditional therapy. However, unfavourable regulatory
and reimbursement scenario and high capital investment amount might hinder the
overall market at a global level.
Based
on indication, the immuno-oncology assays market is segmented into lung cancer,
colorectal cancer, melanoma, bladder cancer, and other cancers. The lung cancer segment
is projected to be the fastest-growing segment during the forecast period, as
major firms are focusing on immuno-oncology research for lung cancer owing to
its increasing incidence.
Based
on products, the immuno-oncology assays market is segmented into consumables
and software. The consumables segment garnered the major immuno oncology assays
market share and is also expected to register the highest CAGR during the
forecast period. The availability of variety, increasing use of reagents in
various oncology therapeutic treatments, continuous research on cancer
immunotherapy is fueling the growth of this segment.
Based
on application, the immuno-oncology assays market is segmented into research
applications and clinical diagnostics. Research applications held significant
market share and are projected to grow with a robust CAGR value during the
forecast period. The increasing significance of biomarker-based drug
development and clinical trials and the awareness of cancer immunotherapy are
the principal factors driving immuno oncology assays market growth.
According
to the region, North America held major revenue in the global immuno oncology
assays market. This is accredited to the increasing cancer cases, the advanced
healthcare infrastructure, and rising adoption of targeted therapy. Continued
research with the favourable scenario for capital funding also boosts the
immuno oncology assays market growth.
The
Asia Pacific immuno oncology assays market will thrive at the highest CAGR
in the projected time frame owing to the rising geriatric population,
increasing cancer cases, and augmenting health awareness.
Prominent Players operating in the global immuno-oncology assays
industry are Thermo Fisher Scientific (US), Roche Diagnostics (Switzerland),
Agilent Technologies (US), and Illumina (US).
Competitive Landscape
●
Thermo Fisher entered into a deal with Invivoscribe Technologies to develop
NGS-based in-vitro diagnostic oncology tests in order to strengthen their
position in the global market
●
Illumina launched its TruSight Oncology 500 assay, which is used to identify
known and emerging tumour biomarkers, this expanded the product portfolio and
explored the potential of the market
Request
a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3364&page=requestsample
Immuno Oncology Assays Market Segmentation
By Product
●
Consumables
● Software
By Technology
● PCR
● Immunoassay
● Ngs
● Flow
Cytometry
● Other
Technologies
By Indication
● Lung
Cancer
● Colorectal
Cancer
● Melanoma
● Bladder
Cancer
● Other
Cancers
By Application
● Research
Applications
● Clinical
Diagnostics
By Region
● Europe
● APAC
● Latin
America
● Rest
of World
Purchase a Copy of this Premium Research Report & Ask For
Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3364&page=askfordiscount
Competitive Landscape:
● Tier
1 players- established companies in the market with a major market share
● Tier
2 players
● Emerging
players which are growing rapidly
● New
Entrants
FutureWise Takeaways
● Growth
prospects
● SWOT
analysis
● Key
trends
● Key
data points affecting market growth
Objectives of the Study:
● To
provide an exhaustive analysis on the global immuno oncology assays market by
product, by technology, by indication by application, and by region
● To
cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
● To
evaluate and forecast micro-markets and the overall market
● To
predict the Immuno Oncology Assays Market Growth, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the rest of the world
● To
record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
● Profiling
of companies to evaluate their market shares, strategies, financials and core
competencies
Inquire
further details about this report at: sales@futurewiseresearch.com
About FutureWise Research:
We specialise
in high-growth niche markets, assuring flexibility, agility and customised
solutions for our clients. Through in-depth market insights and consultancy, we
present our clients with the tools they need to be at the forefront of their
industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise
Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 347 709 4931
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 347 709 4931
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Comments
Post a Comment